Solara Active Pharma Sciences' Cuddalore facility completes EU GMP Inspection
The inspection was carried out jointly by the State Institute for Drug Control (SUKL), Ministry of Health of the Czech Republic and National Authority of Medicines and Health Products (INFARMED), Portugal from February 7 to 9, 2023
<br />
Solara Active Pharma Sciences | 15/02/2023 | By Sudeep Soparkar | 278
Solara Active Pharma Sciences' Cuddalore facility completes WHO PQ inspection
The Cuddalore API site is a multi-product facility
<br />
Solara Active Pharma Sciences | 27/01/2023 | By Sudeep Soparkar | 774
Solara Active Pharma gets EDQM CEP nod for Ibuprofen for Vizag facility
With this key approval, Solara has CEP approval for two manufacturing facilities for Ibuprofen API, the other being its dedicated manufacturing facility located at Puducherry
Solara Active Pharma Sciences | 07/11/2022 | By Sudeep Soparkar | 494
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy